Skip to content Skip to footer
Join our LinkedIn Group and be part of the conversation on AI in life sciences
Login
Login
Close

Meghan Oates-Zalesky 

Meghan Oates‑Zalesky is Chief Marketing Officer at CapeStart and MadeAi, with over 20 years of experience in healthcare technology and life sciences. Previously CMO at Apollo Intelligence, she helped grow the company from a small startup into a global enterprise. A PharmaVOICE Woman of Influence (2021), Meg’s thought leadership has appeared in leading industry publications. She holds degrees from Harvard and the London School of Economics and is a published novelist and avid equestrian.

71 articles published Follow:
systematic literature review process

How to Do an AI-Assisted Systematic Literature Review: A Step-by-Step Guide

BlogMay 14, 2026104Views0Likes0Comments
The Systematic Literature Review Definition: Systematic Literature Review (SLR) is a rigorous, structured, and transparent process of identifying, analyzing, and synthesizing all existing research on a clearly defined question or topic, providing a comprehensive summary and critical evaluation of the evidence. If you’ve ever tried to pull together evidence for a big research question, you’ll…

Read More

madeai-spring-2026

MadeAi Spring 2026 Highlights

WebinarMay 12, 202673Views0Likes0Comments
Watch the MadeAi Spring 2026 Highlights video now! Check out MadeAi’s exclusive Spring 2026 Highlights video featuring our CMO Meghan Oates-Zalesky and Head of Product Angeline Dhas, showcasing the latest AI-native capabilities shaping the future of evidence generation in life sciences. See how organizations are embracing AI-driven solutions from literature review and regulatory submissions to…

Read More

AI Agents Transform Regulatory Content

2026 Prediction #6: AI Agents Will Transform Regulatory Content into a Competitive Asset

BlogApril 28, 202661Views0Likes0Comments
Introduction: The Next Wave of Pharma Innovation In the life sciences, regulatory content has always played a critical role, yet it has rarely been treated as a strategic asset. Documents such as clinical summaries, regulatory submissions, safety reports, and evidence dossiers are essential for compliance, but they are often viewed as static outputs rather than…

Read More

From Capability to Confidence: How to Build Trustworthy AI for RWE Generation in HEOR, Market Access, and Medical Affairs

Building Trustworthy AI for RWE Generation in HEOR, Market Access, and Medical Affairs

White PaperApril 21, 202676Views0Likes0Comments
AI adoption in life sciences keeps stalling at the same point when compliance, traceability, and validation requirements enter the room. Most pilots never make it to regulatory or payer decision-making. MadeAi is built for exactly that gap. By embedding governance, auditability, and human validation into every workflow, HEOR, Market Access, and Medical Affairs teams can…

Read More

i4

MadeAi™ Honored as a Winner in the 2026 Artificial Intelligence Excellence Awards

MadeAi Press ReleaseApril 17, 202649Views0Likes0Comments
Achievement recognizes organizations, products, teams, and individuals delivering measurable results through artificial intelligence CAMBRIDGE, April 9, 2026—MadeAi, Inc. (MadeAi) today announced it has been named a winner in the 2026 Artificial Intelligence Excellence Awards, in the Generative AI category supporting life sciences. Presented by the Business Intelligence Group, the award recognizes organizations, products, teams, and…

Read More